Ethereum Price Targets Up to $20,000 as Wyckoff Breakout Nears

A crypto analyst on X says the Ethereum price is in the late stage of a multi-year accumulation cycle and may rebound sharply. Ethereum price is currently around $2,100–$2,135, roughly 57% below its peak, and the weekly chart is framed as a Wyckoff blueprint. The structure cited includes a 2024 early-year Selling Climax, an Automatic Rally, and a Secondary Test that shaped the current trading range. Key levels for Ethereum price: resistance near $4,700 and Support 1 around $1,549. Two downside “Spring” signals were noted, with the latest “Spring 2” forming just above Support 1. If Support 1 breaks, the next projected buy zone is around $1,065. For traders, the bullish pathway is conditional: Ethereum price could work through staged targets of $10,000, $15,000, and up to $20,000 if the move is confirmed by reclaiming and holding above ~$4,700. A failed breakout would likely delay the rally, extend the range, and keep downside volatility elevated, with consolidation risk after any breakout under the $4,000 area.
Bullish
The core of both summaries is a Wyckoff-based bullish accumulation thesis for Ethereum price, pointing to a potential rebound from a late-stage range. The latest/additional details stress conditional confirmation: Ethereum price needs to reclaim and hold above the ~$4,700 resistance to validate “buy the range.” Support 1 (~$1,549) and a lower projected buy zone (~$1,065) define the downside invalidation path if the range breaks. Short term: traders may watch for a “Spring” formation and whether downside wicks hold near Support 1; failure to defend it can trigger volatility and a deeper move. Medium to long term: if the $4,700 breakout holds, the scenario supports a staged advance toward $10,000, $15,000, and potentially $20,000, followed by likely consolidation risk under ~$4,000. Without breakout confirmation, the move is expected to be delayed and the accumulation range could extend or deepen—limiting upside until resistance is reclaimed.